Literature DB >> 34915517

Gut Microbes and Eye Disease.

Patrick Donabedian1, Elizabeth Dawson2, Qiuhong Li3, Jinghua Chen3.   

Abstract

Microbial symbionts in the gut are increasingly recognized as having important effects on health and disease, but have only recently begun to be linked to diseases of the eye. We review current research on the intestinal microbiota's relationship to ocular disease, focusing on autoimmune uveitis, diabetic retinopathy, age-related macular degeneration, and primary-open angle glaucoma. We discuss findings and limitations of this exciting new area of ophthalmology research and explore possible future disease-modifying treatments.
© 2021 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Age-related macular degeneration; Autoimmune uveitis; Diabetic retinopathy; Glaucoma; Gut microbiome

Mesh:

Year:  2021        PMID: 34915517      PMCID: PMC9198007          DOI: 10.1159/000519457

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   3.031


  91 in total

1.  Glaucoma and Helicobacter pylori: eyes wide shut?

Authors:  Angelo Zullo; Lorenzo Ridola; Cesare Hassan; Vincenzo Bruzzese; Francesco Papini; Dino Vaira
Journal:  Dig Liver Dis       Date:  2012-04-11       Impact factor: 4.088

2.  A Pilot Study to Evaluate the Oral Microbiome and Dental Health in Primary Open-Angle Glaucoma.

Authors:  Daniel Polla; Konstantin Astafurov; Eman Hawy; Leslie Hyman; Wei Hou; John Danias
Journal:  J Glaucoma       Date:  2017-04       Impact factor: 2.503

Review 3.  The microbiome and ophthalmic disease.

Authors:  Adam D Baim; Asadolah Movahedan; Asim V Farooq; Dimitra Skondra
Journal:  Exp Biol Med (Maywood)       Date:  2018-11-21

4.  Immunostaining of heat shock proteins in the retina and optic nerve head of normal and glaucomatous eyes.

Authors:  G Tezel; R Hernandez; M B Wax
Journal:  Arch Ophthalmol       Date:  2000-04

5.  Microbiota-Dependent Activation of an Autoreactive T Cell Receptor Provokes Autoimmunity in an Immunologically Privileged Site.

Authors:  Reiko Horai; Carlos R Zárate-Bladés; Patricia Dillenburg-Pilla; Jun Chen; Jennifer L Kielczewski; Phyllis B Silver; Yingyos Jittayasothorn; Chi-Chao Chan; Hidehiro Yamane; Kenya Honda; Rachel R Caspi
Journal:  Immunity       Date:  2015-08-18       Impact factor: 31.745

6.  C-reactive protein level and risk of aging macula disorder: The Rotterdam Study.

Authors:  Sharmila S Boekhoorn; Johannes R Vingerling; Jacqueline C M Witteman; Albert Hofman; Paulus T V M de Jong
Journal:  Arch Ophthalmol       Date:  2007-10

7.  Increased levels of Helicobacter pylori IgG antibodies in aqueous humor of patients with primary open-angle and exfoliation glaucoma.

Authors:  Jannis Kountouras; Nikolaos Mylopoulos; Anastasios G P Konstas; Christos Zavos; Dimitrios Chatzopoulos; Anna Boukla
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-10-24       Impact factor: 3.117

Review 8.  Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials.

Authors:  Nadja B Kristensen; Thomas Bryrup; Kristine H Allin; Trine Nielsen; Tue H Hansen; Oluf Pedersen
Journal:  Genome Med       Date:  2016-05-10       Impact factor: 11.117

9.  Controlled delivery of tauroursodeoxycholic acid from biodegradable microspheres slows retinal degeneration and vision loss in P23H rats.

Authors:  Laura Fernández-Sánchez; Irene Bravo-Osuna; Pedro Lax; Alicia Arranz-Romera; Victoria Maneu; Sergio Esteban-Pérez; Isabel Pinilla; María Del Mar Puebla-González; Rocío Herrero-Vanrell; Nicolás Cuenca
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

10.  Periodontitis and the subsequent risk of glaucoma: results from the real-world practice.

Authors:  Kuo-Ting Sun; Te-Chun Shen; Shih-Chueh Chen; Chia-Ling Chang; Ching-Hao Li; Xin Li; Kalaiselvi Palanisamy; Ning-Yi Hsia; Wen-Shin Chang; Chia-Wen Tsai; Da-Tian Bau; Chi-Yuan Li
Journal:  Sci Rep       Date:  2020-10-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.